Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001662487 | SCV001872231 | benign | not provided | 2018-09-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001662487 | SCV005272399 | benign | not provided | criteria provided, single submitter | not provided | ||
Central Research Laboratory, |
RCV000497692 | SCV000590807 | pathogenic | Congenital heart disease | 2017-01-07 | no assertion criteria provided | clinical testing | |
Reproductive Health Research and Development, |
RCV000497692 | SCV001142381 | benign | Congenital heart disease | 2020-01-06 | no assertion criteria provided | curation | NG_008177.2(NM_002052.4):c.617-64G>C in the gene GATA4 has an allele frequency of 0.188 in European (non-Finnish) subpopulation in the gnomAD database. 337 homozygous occurrences are observed in the gnomAD database. This evidence suggests the variant to be classified as benign. ACMG/AMP criteria applied: BA1, BS2. |
Genome Diagnostics Laboratory, |
RCV001579933 | SCV001809097 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579933 | SCV001927688 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001579933 | SCV001951502 | benign | not specified | no assertion criteria provided | clinical testing |